Woods et al. revealed that HDACis (inhibitors targeting the epigenetic regulatory family of histone deacetylases) up-regulated PD-L1 and PD-L2 (to a lesser degree) in melanoma-bearing mice due to rapidly increased histone acetylation. The gene discussed is CD274; the disease is melanoma.